GlassScriptPhysician profile
Daniel Joseph Leberer
NPI 1134432347
$7,478.11
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,102 · 2020: $1,715 · 2021: $351 · 2022: $907 · 2023: $112 · 2024: $145 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,984.51 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,523.49 | 2019-2020 | |
| Stryker Corporation | $1,272.42 | 2019 | |
| Medtronic USA, INC. | $491.12 | 2019-2020 | |
| Axonics, INC. | $382.87 | 2020-2024 | Axonics |
| Medtronic, INC. | $302.41 | 2021-2025 | Interstim, Ligasure |
| Exact Sciences Corporation | $215.60 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Tela Bio, INC. | $151.45 | 2022 | |
| Cook Medical LLC | $147.07 | 2019-2022 | |
| Boston Scientific Corporation | $7.17 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Leberer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.